CFDE Data Portal | Search ZRSR2P1

	Label	Description
	ZRSR2P1 Gene (Entity type)	ENSG00000212643 - ZRSR2 pseudogene 1
	GSE198930 prunetin AGS 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE128885 deferiprone macrophage 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE190178 MEK CDK8 inhibition 1 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE102505 tunicamycin 6 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE174745 dopamine neuron 1 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE126258 GSE126739 c-Myc inhibition 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE128885 deferiprone macrophage 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 9 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 cisplatin 3 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS

ZRSR2P1

ENSG00000212643 - ZRSR2 pseudogene 1

GSE198930 prunetin AGS 1 v 0 human dn

A Gene Set from LINCS

GSE128885 deferiprone macrophage 0 v 2 human up

A Gene Set from LINCS

GSE190178 MEK CDK8 inhibition 1 v 4 human up

A Gene Set from LINCS

GSE102505 tunicamycin 6 v 3 human up

A Gene Set from LINCS

GSE174745 dopamine neuron 1 v 8 human up

A Gene Set from LINCS

GSE126258 GSE126739 c-Myc inhibition 1 v 0 human up

A Gene Set from LINCS

GSE128885 deferiprone macrophage 0 v 3 human up

A Gene Set from LINCS

GSE100148 EZH2 inhibition 9 v 5 human up

A Gene Set from LINCS

GSE216043 cisplatin 3 v 0 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.